Translations:Ipragliflozin/6/en

Revision as of 21:00, 20 February 2024 by FuzzyBot (talk | contribs) (Importing a new version from external source)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Ipragliflozin (INN, trade names Suglat) is a pharmaceutical drug for treatment of type 2 diabetes. Ipragliflozin, jointly developed by Astellas Pharma and Kotobuki Pharmaceutical, was approved in Japan on January 17, 2014, and in Russia on May 22, 2019.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Ipragliflozin/6/en&oldid=118274"